Literature DB >> 9327827

The biology of restenosis.

C Bauters1, J M Isner.   

Abstract

Recent studies have allowed a better understanding of the biology of restenosis. Neointimal thickening--also referred to as neointimal hyperplasia--occurs in response to experimental arterial injury. This process involves different steps which include smooth muscle cell activation, proliferation, and migration, and the production of extracellular matrix. Neointimal thickening has been identified as one of the mechanisms of restenosis after balloon angioplasty in humans. The factors which control neointimal thickening include growth factors, hormonal factors, and mechanical factors. Delinquent reendothelialization has been shown to have a permissive impact on smooth muscle cell proliferation. In addition to neointimal thickening, arterial remodeling also plays a major role in restenosis. Studies performed on animals and in human subjects have established the potential for "constrictive remodeling" to reduce the vessel lumen after angioplasty. Restenosis thus appears as a multifactorial entity that may be addressed in the future by a combined mechanical and pharmacological approach.

Entities:  

Mesh:

Year:  1997        PMID: 9327827     DOI: 10.1016/s0033-0620(97)80003-5

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  42 in total

Review 1.  Photodynamic therapy: shedding light on restenosis.

Authors:  R Mansfield; S Bown; J McEwan
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 2.  Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis.

Authors:  Florian Blaschke; Dennis Bruemmer; Ronald E Law
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis.

Authors:  Prakash Krishnan; K-Raman Purushothaman; Meerarani Purushothaman; Irene C Turnbull; Arthur Tarricone; Miguel Vasquez; Sachin Jain; Usman Baber; Rheoneil A Lascano; Annapoorna S Kini; Samin K Sharma; Pedro R Moreno
Journal:  Atherosclerosis       Date:  2016-06-30       Impact factor: 5.162

4.  Evidence supporting changes in Nogo-B levels as a marker of neointimal expansion but not adaptive arterial remodeling.

Authors:  Jacek J Paszkowiak; Stephen P Maloney; Fabio A Kudo; Akihito Muto; Desarom Teso; Reuben C Rutland; Tormod S Westvik; Jose M Pimiento; George Tellides; William C Sessa; Alan Dardik
Journal:  Vascul Pharmacol       Date:  2006-11-18       Impact factor: 5.773

Review 5.  Nanocarriers for tracking and treating diseases.

Authors:  Sean Marrache; Rakesh Kumar Pathak; Kasey L Darley; Joshua H Choi; Dhillon Zaver; Nagesh Kolishetti; Shanta Dhar
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

6.  Age-related neointimal hyperplasia is associated with monocyte infiltration after balloon angioplasty.

Authors:  Sammy D D Eghbalieh; Paraag Chowdhary; Akihito Muto; Kenneth R Ziegler; Fabio A Kudo; Jose M Pimiento; Issa Mirmehdi; Lynn S Model; Yuka Kondo; Toshiya Nishibe; Alan Dardik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-10-19       Impact factor: 6.053

7.  A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit.

Authors:  Natalie K Schiller; Alvin M Timothy; Harmeet S Aurora; I-Li Chen; David H Coy; William A Murphy; Donald L Akers; Vivian A Fonseca; Philip J Kadowitz; Dennis B McNamara
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

Review 8.  Cardiac repair with adult bone marrow-derived cells: the clinical evidence.

Authors:  Buddhadeb Dawn; Ahmed Abdel-Latif; Santosh K Sanganalmath; Michael P Flaherty; Ewa K Zuba-Surma
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 9.  Induction of vascular atrophy as a novel approach to treating restenosis. A review.

Authors:  Seung-Kee Min; Richard D Kenagy; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2007-10-22       Impact factor: 4.268

10.  Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis.

Authors:  Luis A Brito; Saradha Chandrasekhar; Steven R Little; Mansoor M Amiji
Journal:  Biomed Eng Online       Date:  2010-09-27       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.